<DOC>
	<DOCNO>NCT02391584</DOCNO>
	<brief_summary>Study assess safety efficacy XprESS device transnasal Eustachian tube dilation .</brief_summary>
	<brief_title>XprESS Eustachian Tube Dilation Study</brief_title>
	<detailed_description>Prospective , multicenter , randomize control trial compare balloon dilation Eustachian tube continue medical management treatment persistent Eustachian tube dysfunction .</detailed_description>
	<criteria>â‰¥18 year old Have diagnose symptom chronic Eustachian tube dysfunction le 12 month prior enrollment Have record fail medical management Eustachian tube dysfunction Have evidence internal carotid artery dehiscence Be pregnant time enrollment Be currently participate drug device study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>